Chapel Hill, NC, United States of America

Luis Miguel Molina Y Vedia


Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 167(Granted Patents)


Company Filing History:


Years Active: 1996-1998

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Luis Miguel Molina Y Vedia

Introduction

Luis Miguel Molina Y Vedia is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of medicine, particularly in the treatment of respiratory conditions. With a total of five patents to his name, his work focuses on innovative methods to improve patient care.

Latest Patents

Among his latest patents is a method of treating retained asthma pulmonary secretions. This method facilitates the clearance of retained pulmonary secretions in a subject using lantibiotics. The process involves administering an effective amount of a lantibiotic to the lungs, preferably through topical application to the respiratory epithelia. This can be achieved by generating an aerosol that is inhaled by the subject. Duramycin is identified as a preferred lantibiotic for this treatment. The method is applicable for disorders such as cystic fibrosis, chronic bronchitis, and asthma. Additionally, he has developed a method for combatting tuberculosis by administering a lantibiotic to a subject in need of treatment.

Career Highlights

Luis Miguel Molina Y Vedia has worked with Molichem Medicines, Inc. and the University of North Carolina at Chapel Hill. His career reflects a commitment to advancing medical treatments through innovative research and development.

Collaborations

Some of his notable coworkers include Monroe Jackson Stutts and Richard C Boucher. Their collaborative efforts have contributed to the advancement of medical science and the development of effective treatments.

Conclusion

Luis Miguel Molina Y Vedia's work exemplifies the impact of innovation in medicine. His patents and collaborations highlight his dedication to improving health outcomes for patients with respiratory conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…